The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Eleva is exploring the potential of one of its drug candidates for first-in-line therapy of COVID-19.
read more
Review the latest news and information on the Coronavirus Pandemic.
read more
Nabriva announced the CHMP of the EMA has adopted a positive opinion recommending approval of XENLETA for community-acquired pneumonia.
read more
AstraZeneca Pharmaceuticals
AstraZeneca has taken the next steps in its commitment to broad and equitable global access to the University of Oxford’s COVID-19 vaccine.
read more
Review the latest news and information on the Coronavirus Pandemic.
read more
Neurotrope announced the launch of a new long-term study of Bryostatin-1 for the treatment of patients with Alzheimer's disease.
read more
Cellenkos announced the FDA has cleared the way to initiate a trial of CK0802 for COVID-19 associated acute respiratory distress syndrome (ARDS).
read more
Review the latest news and information on the Coronavirus Pandemic.
read more
Bird Rock Bio has filed an IND application with the FDA for a phase 2 clinical study of nimacimab in patients with diabetic kidney disease, focal ...
read more
CTI BioPharma has enrolled the first patient in the Phase 3 PRE-VENT trial (NCT04404361) of pacritinib in hospitalized patients with severe COVID-19.
read more
Review the latest news and information on the Coronavirus Pandemic.
read more
Apellis has initiated a study of APL-9, an investigational C3 inhibitor designed for acute interventions, in COVID-19 patients with respiratory ...
read more
Seelos announced the initiation of a preclinical study of SLS-004 in Parkinson’s disease through an all-in-one lentiviral vector targeting the ...
read more
Review the latest news and information on the Coronavirus Pandemic.
read more
The FDA granted approval to VESIcare LS oral suspension for the treatment of neurogenic detrusor overactivity in children ages two years and older.
read more